We are live on ! Find out more
ECP

Elk Creek Partners Portfolio holdings

AUM $582M
1-Year Est. Return 10.23%
This Fund
S&P 500
This Quarter Est. Return
+19.66%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
AUM
$870M
AUM Growth
-$294M
Cap. Flow
-$431M
Cap. Flow %
-49.59%
Top 10 Hldgs %
24.31%
Holding
125
New
9
Increased
9
Reduced
74
Closed
33

Sector Composition

Rank Sector Weight
1 Healthcare 32%
2 Technology 14.68%
3 Consumer Discretionary 12.49%
4 Industrials 10.97%
5 Communication Services 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDLS icon
51
Noodles & Co
NDLS
$111M
$7.82M 0.9%
176,403
-8,060
-4% -$356K
KNSL icon
52
Kinsale Capital Group
KNSL
$8.12B
$7.43M 0.85%
73,130
-24,970
-25% -$2.48M
MEI icon
53
Methode Electronics
MEI
$496M
$7.33M 0.84%
186,360
-17,431
-9% -$633K
VCRA
54
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$7.32M 0.84%
352,685
-165,095
-32% -$3.62M
CATM
55
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$7.28M 0.84%
163,055
-15,271
-9% -$580K
PRMW
56
DELISTED
Primo Water Corporation
PRMW
$7.21M 0.83%
642,737
-23,051
-3% -$256K
TMX
57
DELISTED
Terminix Global Holdings, Inc.
TMX
$7.21M 0.83%
+186,365
New +$7.93M
MTZ icon
58
MasTec
MTZ
$20.8B
$7.05M 0.81%
109,814
-44,917
-29% -$2.96M
FRPT icon
59
Freshpet
FRPT
$2.93B
$6.93M 0.8%
117,253
-52,961
-31% -$2.82M
PETQ
60
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$6.76M 0.78%
270,000
+41,090
+18% +$1.02M
FBK icon
61
FB Financial Corp
FBK
$3.02B
$6.63M 0.76%
167,448
-15,718
-9% -$602K
GBT
62
DELISTED
Global Blood Therapeutics, Inc.
GBT
$6.58M 0.76%
+82,759
New +$4.9M
MTDR icon
63
Matador Resources
MTDR
$6.2B
$6.51M 0.75%
362,576
-193,820
-35% -$2.9M
WNS
64
DELISTED
WNS Holdings
WNS
$6.51M 0.75%
98,415
-53,701
-35% -$3.34M
EVRI
65
DELISTED
Everi Holdings
EVRI
$6.44M 0.74%
+479,820
New +$5.47M
ICUI icon
66
ICU Medical
ICUI
$4.21B
$6.4M 0.74%
+34,219
New +$5.89M
MDRX
67
DELISTED
Veradigm Inc. Common Stock
MDRX
$6.2M 0.71%
631,830
-225,862
-26% -$2.38M
VRRM icon
68
Verra Mobility
VRRM
$804M
$6.18M 0.71%
441,886
-120,624
-21% -$1.73M
LITE icon
69
Lumentum
LITE
$55.5B
$6.09M 0.7%
76,780
-41,526
-35% -$2.72M
MTSC
70
DELISTED
MTS Systems Corp
MTSC
$6.06M 0.7%
126,180
+16,221
+15% +$862K
REVG
71
DELISTED
REV Group
REVG
$6.02M 0.69%
492,115
-252,878
-34% -$3.2M
ECHO
72
DELISTED
Echo Global Logistics, Inc.
ECHO
$6M 0.69%
289,681
+68,206
+31% +$1.42M
CLVS
73
DELISTED
Clovis Oncology, Inc.
CLVS
$5.99M 0.69%
574,616
-2,498,934
-81% -$18.2M
TSC
74
DELISTED
TriState Capital Holdings, Inc.
TSC
$5.97M 0.69%
228,683
-21,443
-9% -$510K
EVOP
75
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$5.91M 0.68%
223,797
-101,724
-31% -$2.8M

Similar funds

Elk Creek Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Elk Creek Partners held 125 positions worth $870M, down 25% from $1.16B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Elk Creek Partners withdrew a net $431M in Q4 2019, closing 33 positions and reducing 74 holdings. Its most notable exit was Exact Sciences, an estimated $12.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Elk Creek Partners opened a new position in Terminix Global Holdings, Inc. worth $7.21M.

  • Elk Creek Partners's largest Q4 2019 buy was Terminix Global Holdings, Inc.: 186,365 shares worth $7.21M.
  • Elk Creek Partners added most to ViewRay, Inc. in Q4 2019, an estimated $2.54M increase.
  • Elk Creek Partners's biggest Q4 2019 reduction was Clovis Oncology, Inc., cutting an estimated $18.2M.
  • Elk Creek Partners fully exited Exact Sciences in Q4 2019, selling an estimated $12.2M.
  • Elk Creek Partners's ten largest holdings make up 24% of its $870M portfolio in Q4 2019.
  • Elk Creek Partners opened 9 new positions and closed 33 in Q4 2019.
  • Elk Creek Partners's portfolio value fell 25% quarter-over-quarter to $870M.

Based on Elk Creek Partners's 13F filing for Q4 2019, filed 14 Feb 2020.